Impact of COVID-19 pandemic on the continuity of care for dermatologic patients on systemic therapy during the period of strict lockdown
Author(s) -
Diala Alshiyab,
Firas AlQarqaz,
Jihan Muhaidat
Publication year - 2020
Publication title -
annals of medicine and surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 23
ISSN - 2049-0801
DOI - 10.1016/j.amsu.2020.11.056
Subject(s) - medicine , pandemic , isotretinoin , pharmacy , discontinuation , dermatology , exacerbation , systemic therapy , acne , covid-19 , disease , intensive care medicine , family medicine , infectious disease (medical specialty) , cancer , breast cancer
The world has changed dramatically since the COVID-19 pandemic began. Jordan was among countries which enforced early lock-down for most non-vital services. Health care was mainly directed to cope with COVID-19 cases. The pandemic posed challenges for all patients, including dermatology patients especially those on systemic treatments. This resulted in interruption of medical care and exacerbation of pre-existing skin diseases for many patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom